BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2014
View Archived Issues
Selective blockade of PTH activity by stapled peptide ATSP-10814
Read More
Clinical data show improved therapeutic efficacy of an antiasthmic drug in patient subtypes
Read More
Eisai establishes new joint research agreements for malaria
Read More
MGAT2 inhibitors designed for effects on obesity and related disorders
Read More
Series B financing at Pulmologix to fund new asthma drug
Read More
Pluristem pursues development strategy in Japan
Read More
MedGenesis and Pfizer enter into agreement for potential treatments for PD
Read More
Merck Serono and Lupin form strategic partnership targeting emerging markets
Read More
Quest PharmaTech and AD Biotech end investment agreement
Read More
Genisphere raises funds to develop targeted drug delivery technology
Read More
Trellis Bioscience and ContraFect's universal influenza treatment receives NIAID grant
Read More
Autologous mesenchymal stem cell transplant evaluated in phase I multiple sclerosis trial
Read More
Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects
Read More
Clinical and preclinical data presented for a novel antibacterial, AAI-101
Read More
Treprost injection solution launched in Japan
Read More
Phase Ib/II trial of PEGPH-20 in combination with modified FOLFIRINOX to resume
Read More
Boehringer Ingelheim and CureVac to develop therapeutic cancer vaccine CV9-202
Read More
Neuraltus Pharmaceuticals' reports phase II data for NP-001
Read More
Alnylam Pharmaceuticals presents new preclinical results on ALN-CC5
Read More
Auxilium and QLT respond to Endo's acquisition proposal
Read More
Domainex discloses IKK-epsilon/TBK1 inhibitors
Read More
DPP IV inhibitors revealed in Hitgen patent
Read More
Bayer scientists report development of AKR1C3 inhibitors
Read More
Selvita describes 5-HT6 receptor antagonists
Read More
Novartis describes PI3K inhibitors in recent patent
Read More
Bayer to spin out MaterialScience polymers business and focus on healthcare and agrochemicals
Read More
Japanese approval of Aricept for dementia with Lewy bodies
Read More
FDA approves Trulicity for type 2 diabetes
Read More
Lymphoseek awarded U.S. orphan drug designation for head and neck cancers
Read More